Technology

The TandemHeart System ventricular assist device by CardiacAssist assists heart failure patients survive both heart attacks and high risk procedures, while providing versatility to physicians in choos...

The intra-aortic balloon (IAB) is an minimally invasive technology designed to enhance blood flow to the heart and other organs for patients with diminished heart function.

...

Abiomed Inc. recently announced the start of the IMPELLA 2.5 pilot study in the U.S. with the enrollment of the first patient at William Beaumont Hospital in Detroit, MI....

The EXCOR TAH-t has received CE approval with the CardioWest TAH-t....

ABIOMED Inc. is commencing its pilot clinical trial in the U.S. for the IMPELLA 2.5 minimally invasive ventricular assist device (VAD) after recent FDA approval....

The AB5000 Circulatory Support System provides temporary support for one or both sides of the natural heart in circumstances where the heart has failed, giving the patient’s heart the opportunity to r...

Impella Recover technology, which includes the Recover LP 2.5, LD, LP 5.0 and the RD, are commercially available in European centers.
...

Enabling the TandemHeart percutaneous ventricular assist device to provide blood flow of up to five liters per minute, the TandemHeart Transseptal Cannula – Enhanced Flow (THTC-EF) from CardiacAssist ...